The emergence of drug resistant strains of tubercle bacilli has proved to be one of the main drawbacks to the successful use of antimicrobial therapy in pulmonary tuberculosis. Resistant strain also may be obtained readily by in vitro methods. Nevertheless, it has proven difficult to study this phenomenon experimentally because of the inability to induce regularly a high degree of drug resistance in cultures subjected to exposure to drugs in the animal body. This report summarizes the results of drug susceptibility determinations of several different strains of tubercle bacilli recovered from guinea pigs, mice, and rabbits after prolonged treatment.
MATERIALS AND METHODS
Mice. For recovering tubercle bacilli from mice the following method was used: One-half of the spleen and one entire lung were ground in a sterile mortar with a small amount of sterile physiological saline to produce a thick paste. After a little further dilution, approximately 1.0 ml of this suspension was injected subcutaneously in the inguinal region of each of 2 guinea pigs. Cultures were made directly from this suspension by planting a double loopful on solid medium. The material then was digested with 3 per cent sodium hydroxide, concentrated, and again planted on tubes of solid medium.
Rabbits and guinea pigs. Caseous material when available was removed aseptically with a platinum spade, emulsified in a small amount of sterile physiological saline, and planted directly on tubes of solid medium before and after sodium 1 This study was aided by grants from the Division of Research Grants and Fellowships of the National Institutes of Health, Public Health Service. ' Presented in part at the 52nd annual meeting of the Society of American Bacteriologists, Boston, April, 1952. hydroxide digestion. Other lesions from various organs were ground in a mortar and handled in the same manner as described under mice. Material for guinea pig inoculation always was removed before any sodium hydroxide was added.
The egg-yolk, potato, glycerin medium recommended by the American Trudeau Society (1946) was used. Direct drug sensitivity tests were made at the time of the original planting by distributing equal portions of the material on tubes of medium containing graded concentrations of the drug as well as on control tubes without drug. Sufficient streptomycin was added to the medium before inspissation to give concentrations of 10, 50, and 500 pg per ml Chemical analysis of the final medium indicates that the concentrations of available streptomycin are then approximately 3.5, 15, and 200 ug per ml, respectively. The p-amino-salicylic acid concentrations used were 1.0, 10, and 100 pg per ml.
Comparison was made of the lag period and the final amount of growth in each of the drug containing tubes with that in the control tubes. strain, H37Ra, as described previously (Steenken et al., 1952a) . Ninety-seven days after infection streptomycin was started in dosage of 15 mg once daily intramuscularly and continued for 300 consecutive days. Table 2 shows the results of streptomycin sensitivity tests of the strains of tubercle bacilli recovered from 5 chronic abscesslike lesions in 3 guinea pigs after 300 days of streptomycin treatment.
It may be seen that all 5 strains were still completely sensitive to streptomycin. The amount of growth obtained in the control tubes from 4 of these lesions was moderately heavy, indicating that large numbers of viable tubercle bacilli were present in the caseous material from these lesions.
Mice. The finding of drug resistant strains of tubercle bacilli in mice treated with streptomycin has been reported by Youmans and co-workers (Youmans et al., 1949; Williston and Youmans, 1950) and by Lenert and Hobby (1949) . In an 5 mg of p-amino-salicylic acid once daily subcutaneously, p-amino-salicylic acid in the amount of 1 per cent in the diet, or p-amino-salicylic acid In a second experiment a total of 81 C57 black mice were infected intravenously, 27 with 0.25 mg (dry weight) of each of the following human virulent strains of tubercle bacilli: H37Rv, Campbell, and Erdman. Treatment was started immediately after infection with either streptomycin alone in dosage of 1.5 mg once a day tissues of the treated mice, and the streptomycin susceptibility (subculture method) of each recovered strain.
It may be seen that tubercle bacilli were cultured from all but one of the 54 treated mice. For each of the infecting strains there was only one mouse from which moderately or highly resistant organisms were obtained. Of the 53 positive cultures, only 3 (6 per cent) were moderately or highly resistant; 32 (60 per cent) ex- Table 4 shows the results of the cultures made from the hibited a slight loss of susceptibility but were still inhibited by 5.0 pg of strepomycin per ml; and 18 (34 per cent) were still completely sensitive to streptomycin. About half of the tests were repeated in modified Proskauer and Beck's liquid synthetic medium, and none demonstrated any more drug resistance by this method. The results of the direct tests on solid medium were not significantly different, only 4 cultures (7.5 per cent) showing a moderate or high degree of resistance. All of the cultures remained sensitive to p-amino-salicylic acid.
The difference in the streptomycin susceptibility of strains recovered from mice treated with streptomycin alone as compared with those now been recovered from rabbits treated for treated with the combination of streptomycin prolonged periods with antituberculous agents and p-amino-salicylic acid was not striking. Of after acute miliary tuberculosis had been es- (Steenken et al., 1952b) , usually 2 to 4 weeks after infection. Therapy consisted of intramuscular injections of 75 or 150 mg of cultures of tubercle bacilli recovered from 10 different rabbits, 9 having been treated without interruption for at least 1 year, none was moderately or highly resistant to streptomycin. Nine of the cultures, however, showed a slight loss of susceptibility or borderline resistance. The case of rabbit no. 128 is especially interesting. After and from caseous abscesses in both eyes and in both testicles. All 5 cultures showed a slight loss of susceptibility, requiring 2.5 ug of streptomycin per ml of liquid medium to inhibit growth. Rabbit no. 391 also was treated with streptomycin for 1 year, after which positive cultures were obtained from the lung, from an abscess in the left testicle, and from a caseous lesion in the left eye. All 3 of these cultures were still sensitive to streptomycin.
Other rabbits have been infected by the inhalation of aerosolized suspensions of the Ravenel strain of bovine tubercle bacilli and treatment delayed until chronic caseous pneumonic and cavitary lesions were evident in the chest roentgenograms. The results of such treatment will be described elsewhere (Steenken et al., 1953) . Residual cavitary lesions remained in some animals after 1 year of antimicrobial therapy. Table 6 shows the results of cultures made from these lesions and the drug sensitivity of the recovered tubercle bacilli.
It may be seen that from one rabbit (no. 492), which had a large persistent pulmonary cavity after 8 months of streptomycin treatment, the recovered tubercle bacilli were moderately resistant to streptomycin. Of the other 5 positive cultures, however, 3 still retained sensitivity to streptomycin, and 2 showed only a slight loss of susceptibility.
DISCSSION
It is evident from these results that insofar as the emergence to predominance of drug resistant populations is concerned, tubercle bacilli behave differently in experimental animals than in human beings with pulmonary tuberculosis. Using the same techniques as those described here, it was found that the majority of patients with pulmonary tuberculosis who still had positive cultures after 4 months of treatment with streptomycin alone yielded strains of tubercle bacilli with a moderate or high degree of resistance to the drug (Bernstein et al., 1948) .
In guinea pigs with an acute tuberculous infection, prolonged treatment with streptomycin does not favor the production of highly drug resistant strains of tubercle bacilli in any but a very small percentage of animals. Realizing that the type of lesion from which streptomycin resistant organisms are recovered most rapidly and most frequently is the chronic pulmonary cavity, it was thought that perhaps a chronic abscess-like lesion in the guinea pig might yield resistant organisms. Accordingly, the experiment was set up whereby chronic caseous lesions were produced in the organs of guinea pigs whose resistance to infection had been increased by previous vaccination. Even after prolonged streptomycin treatment of guinea pigs with such lesions, however, and despite the fact that large numbers of tubercle bacilli were recovered from these chronic lesions at the end of treatment, the recovered organisms still retained their sensitivity to the drug.
It is difficult to explain the discrepancy in the results reported herein and those obtained by Youmans and co-workers (Youmans et al., 1949; Williston and Youmans, 1950) , who described the finding of streptomycin resistant strains in a large percentage of mice treated with streptomycin for 155 days. Their sensitivity tests were performed by subculture method, using either modified Proskauer and Beck's liquid medium with serum or solid egg-yolk agar medium. Although the results obtained by these methods would not be expected exactly to duplicate those found with the technique described in this paper, it has been the experience of this laboratory that the differences would not be great enough to account for the over-all discrepancy. One point of definite variance was the severity of the infection as indicated by the mean survival time of the untreated control mice: 14.6 days in Youmans' first experiment; 44.4 in his second; and 58 to 69 in the second experiment reported here. It is possible that larger infecting inocula will be associated with a higher incidence of recoverable drug resistant populations of tubercle bacilli.
At any rate, the combined administration of streptomycin and p-amino-salicylic acid does not have the same effect on the emergence of drug resistant organisms in mice as it does in human beings. In the latter it is well established that the combined treatment delays the emergence to predominance of drug resistant tubercle bacilli, whereas in mice it has been demonstrated by Williston and Youmans (1950) Rabbits. Eighteen positive cultures were obtained from 10 rabbits infected intravenously with virulent bovine tubercle bacilli of the Ravenel strain and treated for periods up to 16 months with streptomycin or the combination of streptomycin and viomycin. None of these cultures proved to be moderately or highly resistant to streptomycin; 9 showed a slight loss of susceptibility or borderline resistance. In another group of rabbits with chronic caseous and cavitary lung lesions, resistant tubercle bacilli were obtained from one after 8 months of streptomycin treatment, and sensitive or only slightly resistant cultures from 4 others after treatment for as long as one year.
Moderately or highly resistant strains of tubercle bacilli have been obtained from human beings with pulmonary tuberculosis treated with streptomycin alone in a high percentage of cases, using the same methods as those described here. It is thus apparent that there are certain factors operating in experimental tuberculosis of animals, as contrasted with the disease in man, which tend to suppress the emergence of a high degree of bacterial resistance during drug treatment. Further investigation of these factors may broaden our understanding of the whole phenomenon of drug resistance.
